Liver cancer combo therapy shows promise in major trial
NCT ID NCT02435953
First seen Jan 07, 2026 · Last updated May 20, 2026 · Updated 23 times
Summary
This study tested whether combining two procedures—chemoembolization (TACE) and radiofrequency ablation (RFA)—works better than TACE alone for people with intermediate-stage liver cancer. 241 adults with 2 to 10 liver tumors took part. The goal was to see if the combo could delay cancer growth and improve survival. This is a disease control approach, not a cure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Minimally Invasive Interventional Division, Medical Imaging Center, Sun Yat-sen University Cancer Center,
Guangzhou, Guangdong, 500060, China
Conditions
Explore the condition pages connected to this study.